FDA关于美国本土已上市药品残留溶剂的指导原则-20080806

Residual Solvents in Drug Products Marketed in the United States [PDF]

Chemistry

Draft

8/6/2008

http://www.fda.gov/cder/guidance/

8179dft.pdf (57.77k)

上一篇:急性肾衰与脑出血   下一篇:引入酶切位点的话如何设计LINKER?
ad
ad